Market Research Logo

Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2015

Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2015’, provides an overview of the Human papillomavirus (HPV) Associated Cancer’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Human papillomavirus (HPV) Associated Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Human papillomavirus (HPV) Associated Cancer and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Human papillomavirus (HPV) Associated Cancer
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Human papillomavirus (HPV) Associated Cancer and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Human papillomavirus (HPV) Associated Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Human papillomavirus (HPV) Associated Cancer pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Human papillomavirus (HPV) Associated Cancer
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Human papillomavirus (HPV) Associated Cancer pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Introduction
Global Markets Direct Report Coverage
Human papillomavirus (HPV) Associated Cancer Overview
Therapeutics Development
Pipeline Products for Human papillomavirus (HPV) Associated Cancer - Overview
Pipeline Products for Human papillomavirus (HPV) Associated Cancer - Comparative Analysis
Human papillomavirus (HPV) Associated Cancer - Therapeutics under Development by Companies
Human papillomavirus (HPV) Associated Cancer - Therapeutics under Investigation by Universities/Institutes
Human papillomavirus (HPV) Associated Cancer - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Human papillomavirus (HPV) Associated Cancer - Products under Development by Companies
Human papillomavirus (HPV) Associated Cancer - Products under Investigation by Universities/Institutes
Human papillomavirus (HPV) Associated Cancer - Companies Involved in Therapeutics Development
3SBio Inc.
Admedus Ltd
Advaxis, Inc.
Antigen Express, Inc.
Bionor Pharma ASA
Cancer Research Technology Limited
Cancer Therapeutics CRC Pty Ltd
Chong Kun Dang Pharmaceutical Corp.
Etubics Corporation
EyeGene, Inc.
Formune S.L.
Genexine, Inc.
iBio, Inc.
Immunovaccine, Inc.
Inovio Pharmaceuticals, Inc.
Karyopharm Therapeutics, Inc.
Kite Pharma, Inc.
MedImmune, LLC
Merck & Co., Inc.
Novartis AG
Onconova Therapeutics, Inc.
Oryx GmbH & Co. KG
Prima BioMed Ltd.
Profectus BioSciences, Inc.
Redbiotec AG
Shantha Biotechnics Limited
Sirnaomics, Inc.
Theravectys SA
Transgene SA
Vaccibody AS
Virometix AG
ViroStatics, srl
Human papillomavirus (HPV) Associated Cancer - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
AEH-10p - Drug Profile
alpelisib - Drug Profile
Antibodies to Target E6 for HPV Associated Cancer - Drug Profile
Antibodies to Target E7 for HPV Associated Cancer - Drug Profile
Cell Therapy for HPV Associated Cancers - Drug Profile
Cell Therapy for HPV-Associated Cancer and Cervical Cancer - Drug Profile
Cell Therapy for HPV-Associated Cancer and Head and Neck Cancer - Drug Profile
Cell Therapy to Target HPV-16 E6 Protein for Cancer - Drug Profile
CKD-12201 - Drug Profile
CTX-0197195 - Drug Profile
CTX-0272859 - Drug Profile
CTX-0291736 - Drug Profile
DPV-001 - Drug Profile
DPX-E7 - Drug Profile
durvalumab + tremelimumab - Drug Profile
EDA-HPVE7 - Drug Profile
EG-HPV - Drug Profile
GX-188E - Drug Profile
human papillomavirus (7-valent) vaccine - Drug Profile
human papillomavirus (9-valent) vaccine - Drug Profile
human papillomavirus [Serotype 16] vaccine - Drug Profile
human papillomavirus vaccine - Drug Profile
human papillomavirus vaccine - Drug Profile
human papillomavirus vaccine - Drug Profile
human papillomavirus vaccine [types 6, 11, 16, 18] biosimilar - Drug Profile
INO-3106 - Drug Profile
INO-3112 - Drug Profile
Lm-LLO-ISG15 - Drug Profile
NP-001 - Drug Profile
NTCP-02 - Drug Profile
Peptide to Inhibit HPV E6 Protein for HPV Associated Cancer - Drug Profile
RBT-201 - Drug Profile
rigosertib sodium - Drug Profile
sdCMV-002 - Drug Profile
Small Molecule to Inhibit CDK4, CDK6 and CDK9 for HPV Associated Cancers - Drug Profile
Small Molecules for HPV Associated Cancer - Drug Profile
SSS-08 - Drug Profile
STP-909 - Drug Profile
STP-911 - Drug Profile
TA-CIN - Drug Profile
TG-4001 - Drug Profile
TT-12 - Drug Profile
Vacc-HPV - Drug Profile
Vaccine for HIV and HPV Associated Cancer - Drug Profile
Vaccine for HPV Associated Cancer - Drug Profile
Vaccine for HPV Associated Cancer - Drug Profile
Vaccine for HPV Associated Cancers - Drug Profile
Vaccine for HPV Associated Head and Neck Squamous Cell Carcinoma - Drug Profile
Vaccine for HPV Associated Skin Cancer - Drug Profile
Vaccine HPV Associated Cancer - Drug Profile
Vaccines for HPV Associated Cervical Cancer - Drug Profile
VB-1016 - Drug Profile
verdinexor - Drug Profile
Vicoryx - Drug Profile
Human papillomavirus (HPV) Associated Cancer - Recent Pipeline Updates
Human papillomavirus (HPV) Associated Cancer - Dormant Projects
Human papillomavirus (HPV) Associated Cancer - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Human papillomavirus (HPV) Associated Cancer, H2 2015
Number of Products under Development for Human papillomavirus (HPV) Associated Cancer - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Development, H2 2015
Products under Development by Companies, H2 2015
Products under Development by Companies, H2 2015 (Contd..1)
Products under Development by Companies, H2 2015 (Contd..2)
Products under Investigation by Universities/Institutes, H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by 3SBio Inc., H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Admedus Ltd, H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Advaxis, Inc., H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Antigen Express, Inc., H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Bionor Pharma ASA, H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Cancer Research Technology Limited, H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Cancer Therapeutics CRC Pty Ltd, H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Chong Kun Dang Pharmaceutical Corp., H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Etubics Corporation, H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by EyeGene, Inc., H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Formune S.L., H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Genexine, Inc., H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by iBio, Inc., H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Immunovaccine, Inc., H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Inovio Pharmaceuticals, Inc., H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Karyopharm Therapeutics, Inc., H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Kite Pharma, Inc., H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by MedImmune, LLC, H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Merck & Co., Inc., H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Novartis AG, H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Onconova Therapeutics, Inc., H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Oryx GmbH & Co. KG, H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Prima BioMed Ltd., H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Profectus BioSciences, Inc., H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Redbiotec AG, H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Shantha Biotechnics Limited, H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Sirnaomics, Inc., H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Theravectys SA, H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Transgene SA, H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Vaccibody AS, H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by Virometix AG, H2 2015
Human papillomavirus (HPV) Associated Cancer - Pipeline by ViroStatics, srl, H2 2015
Assessment by Monotherapy Products, H2 2015
Assessment by Combination Products, H2 2015
Number of Products by Stage and Target, H2 2015
Number of Products by Stage and Mechanism of Action, H2 2015
Number of Products by Stage and Route of Administration, H2 2015
Number of Products by Stage and Molecule Type, H2 2015
Human papillomavirus (HPV) Associated Cancer Therapeutics - Recent Pipeline Updates, H2 2015
Human papillomavirus (HPV) Associated Cancer - Dormant Projects, H2 2015
List of Figures
Number of Products under Development for Human papillomavirus (HPV) Associated Cancer, H2 2015
Number of Products under Development for Human papillomavirus (HPV) Associated Cancer - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Products, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Top 10 Targets, H2 2015
Number of Products by Stage and Top 10 Targets, H2 2015
Number of Products by Top 10 Mechanism of Actions, H2 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015
Number of Products by Top 10 Routes of Administration, H2 2015
Number of Products by Stage and Top 10 Routes of Administration, H2 2015
Number of Products by Top 10 Molecule Types, H2 2015
Number of Products by Stage and Top 10 Molecule Types, H2 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report